In a notable shift in strategy, private equity firm CVC Capital Partners is pursuing a sale of FineToday Holdings, a Japanese personal-care company recognized for its Tsubaki shampoo brand. This decision comes on the heels of the postponement of FineToday's initial public offering (IPO) in Tokyo, as reported by Reuters, citing sources familiar with the matter.
Originally, FineToday aimed for a market capitalization of approximately JPY169 billion ($1.08 billion) in its October IPO, a figure that fell short of CVC's internal expectations. Now, CVC is targeting a valuation exceeding $2 billion, which translates to an attractive multiple of around 14-15 times EBITDA. This potential sale has already garnered interest from multiple global buyout firms and at least one strategic investor from China.
FineToday Holdings was established in 2021 following the spin-off of Shiseido's personal-care unit and has since positioned itself as a significant player in the personal-care market. The company has demonstrated robust revenue growth, reporting JPY107.3 billion ($689 million) in revenue for the fiscal year 2024. Notably, FineToday has improved its adjusted EBITDA margin from 15.5% to 21% year-over-year, indicating a strong financial performance.
Geographically, FineToday generates about half of its revenue from international markets, with China contributing 36% and Japan accounting for 44% of total sales in the first half of 2025. This diversified revenue base enhances the company's appeal to potential buyers, particularly in light of the growing demand for personal-care products in Asia.
As for the timeline and next steps, while the exact details remain fluid, CVC's shift towards a sale indicates an urgent need to capitalize on the current market conditions rather than pursue a less favorable IPO route. The private equity firm’s move to sell FineToday could unfold in the coming months, with the aim of maximizing value for its stakeholders.
From a market perspective, this sale could have significant implications for shareholders, employees, and the broader personal-care sector. Should the transaction proceed, it may create ripples in the market, particularly if a strategic buyer from China enters the equation, potentially reshaping competitive dynamics.
On the regulatory front, any sale will require careful navigation of antitrust considerations, especially given the involvement of international buyers. CVC will need to ensure compliance with relevant regulations to facilitate a smooth transaction process.
Overall, CVC Capital Partners' decision to sell FineToday Holdings reflects a strategic pivot aimed at unlocking greater value in a rapidly evolving market landscape.